Papitto Opportunity Connection is hoping to help people struggling with a disease that it claims is "woefully understudied ...
Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...
European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease ...
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
On STAT's Readout LOUD podcast, Jonathan Wosen talks about Genentech shutting down its cancer immunology team, and the ...
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...